Massachusetts Prostate Cancer Coalition is a statewide non-profit organization devoted to providing information and education on prostate cancer for newly diagnosed individuals, survivors, men-at-risk, and their families as well as for health care professionals.
MPCC sponsors research on prostate cancer in collaboration with local hospitals and various health care providers and engages people across the Commonwealth in outreach to increase funding for prostate cancer education and research.
MPCC hosts events, funds local research, provides resources for patients and their families, and provides a platform for learning and discussing the issue of prostate cancer.
Support MPCC by becoming a member, making a donation or attending an event. More information can be found here.
Five Facts about Prostate Cancer
1PrevalenceProstate cancer is the most common (non-skin) cancer in American men.
2Prostate cancer effects 1 in 6 men.1 in 6 men will be diagnosed with prostate cancer during their lifetime. This year in Massachusetts another 4,820 new cases will be diagnosed.
3Second leading cause of cancer death in men.Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. In Massachusetts, 600 men will die from prostate cancer this year.
4Prostate cancer top risk factors.
African-American men are twice as likely to die of prostate cancer as white men. Asian-Americans and Hispanic/Latinos have lower rates of prostate cancer than non-Hispanic white men.
Almost 2 out of 3 prostate cancers are found in men over the age of 65.
5This year 29,720 men will die of prostate cancer.
Yet, most men diagnosed with prostate cancer will not die from it. In fact, more than 2.5 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today. How do we “live with prostate cancer”?
Statistics from The American Cancer Society 2013
We need your support! Become a Member or Donate to MPCC today.
Current smokers, and those who have quit smoking less than 10 years previously, have twice the risk of a recurrence of prostate cancer after surgery, according to new research presented at the European Association of Urology conference in Madrid. Read more read more →
FIU scientists are battling prostate cancer at the cellular level. Researchers from FIU’s Biomolecular Sciences Institute (BSI) and the Herbert Wertheim College of Medicine believe they can eradicate prostate cancer that returns in patients who were treated by castration. Read more read more →